Quoin Pharmaceuticals, Ltd. (QNRX) — Dilution Risk Analysis

Current Snapshot

Quoin Pharmaceuticals, Ltd. (QNRX) has a DilutionWatch score of 62/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
70,294,615 Source

Dilution Risk Score

Score: 62/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 4 8, 424B3 1, SC 13G 1.

FormFiledAccession
4 2026-08-28 0001104659-26-103376
424B3 2026-06-02 0001104659-26-069166
SC 13G 2026-06-02 0001104659-26-069556
4 2026-03-31 0000935836-26-000187
4 2026-02-06 0001104659-26-011608
4 2026-02-06 0001104659-26-011610
4 2026-02-06 0001104659-26-011613
4 2026-02-06 0001104659-26-011615
4 2026-02-06 0001104659-26-011616
4 2026-02-06 0001104659-26-011617

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 12 months Source
Three-year share count growth 7020.49% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 62/10) Source
Cash Runway
12 months Source
Share Count Growth (3-Year)
7020.49% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.